34D5C1776CBD06B9872586D2006D737B Hearing Summary

Representative Rich, bill sponsor, introduced and made opening comments on SB21-098. Current law requires the Prescription Drug Monitoring Program (PDMP), which is administered by the Department of Regulatory Agencies, to track all controlled substances prescribed in Colorado. The program is scheduled to repeal on July 1, 2021. The bill extends the repeal date of the program until September 1, 2028, following a sunset review, and makes the following modifications:

• authorizes the State Board of Pharmacy to identify additional prescription drugs and substances that have potential for abuse and require these prescriptions to be reported to the program;
• authorizes the State Board of Pharmacy to establish data retention policies for the program;
• allows a coroner to grant permission to a deputy coroner to query the program; and
• requires reporting on efforts to seek donations during the department’s SMART Act hearing.

Representative Mullica, bill sponsor, gave opening comments on the bill.

Bill sponsors responded to questions from committee members.

Representative Rich and Representative Mullica gave closing comments on the bill.